Linagliptin and Metformin Extended-Release Tablets and Orthoclone OKT 3
Determining the interaction of Linagliptin and Metformin Extended-Release Tablets and Orthoclone OKT 3 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: linagliptin / metformin
Brand name: Jentadueto, Jentadueto XR
Synonyms: Linagliptin and metformin, Linagliptin and Metformin
Generic Name: muromonab-cd3
Brand name:
Synonyms: Orthoclone OKT 3 (Intravenous), Orthoclone OKT3
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Linagliptin and Metformin Extended-Release Tablets-Orthovisc
- Linagliptin and Metformin Extended-Release Tablets-Orudis
- Linagliptin and Metformin Extended-Release Tablets-Orudis KT
- Linagliptin and Metformin Extended-Release Tablets-Oruvail
- Linagliptin and Metformin Extended-Release Tablets-Orvaten
- Linagliptin and Metformin Extended-Release Tablets-Os-Cal 500+D
- Orthoclone OKT 3-Linagliptin and Metformin Tablets
- Orthoclone OKT 3-Lincocin
- Orthoclone OKT 3-Lincomycin
- Orthoclone OKT 3-Lincomycin Hydrochloride
- Orthoclone OKT 3-Lincomycin Injection
- Orthoclone OKT 3-Lincomycin Oral, Injection